Dr. Reddy's Laboratories Limited

NSEI:DRREDDY 株式レポート

時価総額:₹1.0t

Dr. Reddy's Laboratories マネジメント

マネジメント 基準チェック /24

Dr. Reddy's Laboratoriesの CEO はErez Israeliで、 Apr2018年に任命され、 の在任期間は 6.58年です。 は、会社の株式の0.007%を直接所有しており、その価値は₹ 65.07M 。経営陣と取締役会の平均在任期間はそれぞれ6.6年と2.8年です。

主要情報

Erez Israeli

最高経営責任者

₹197.1m

報酬総額

CEO給与比率n/a
CEO在任期間6.6yrs
CEOの所有権0.007%
経営陣の平均在職期間6.6yrs
取締役会の平均在任期間2.8yrs

経営陣の近況

Recent updates

Are Dr. Reddy's Laboratories Limited (NSE:DRREDDY) Investors Paying Above The Intrinsic Value?

Nov 23
Are Dr. Reddy's Laboratories Limited (NSE:DRREDDY) Investors Paying Above The Intrinsic Value?

Dr. Reddy's Laboratories Limited Just Missed EPS By 12%: Here's What Analysts Think Will Happen Next

Nov 08
Dr. Reddy's Laboratories Limited Just Missed EPS By 12%: Here's What Analysts Think Will Happen Next

Insufficient Growth At Dr. Reddy's Laboratories Limited (NSE:DRREDDY) Hampers Share Price

Nov 01
Insufficient Growth At Dr. Reddy's Laboratories Limited (NSE:DRREDDY) Hampers Share Price

Is Dr. Reddy's Laboratories (NSE:DRREDDY) Using Too Much Debt?

Oct 14
Is Dr. Reddy's Laboratories (NSE:DRREDDY) Using Too Much Debt?

If EPS Growth Is Important To You, Dr. Reddy's Laboratories (NSE:DRREDDY) Presents An Opportunity

Aug 19
If EPS Growth Is Important To You, Dr. Reddy's Laboratories (NSE:DRREDDY) Presents An Opportunity

Dr. Reddy's Laboratories Limited (NSE:DRREDDY) Exceeded Expectations And The Analyst Consensus Has Been Reviewing Its Models

Aug 01
Dr. Reddy's Laboratories Limited (NSE:DRREDDY) Exceeded Expectations And The Analyst Consensus Has Been Reviewing Its Models

The Market Doesn't Like What It Sees From Dr. Reddy's Laboratories Limited's (NSE:DRREDDY) Earnings Yet

Jul 30
The Market Doesn't Like What It Sees From Dr. Reddy's Laboratories Limited's (NSE:DRREDDY) Earnings Yet

Dr. Reddy's Laboratories (NSE:DRREDDY) Seems To Use Debt Rather Sparingly

Jul 12
Dr. Reddy's Laboratories (NSE:DRREDDY) Seems To Use Debt Rather Sparingly

Dr. Reddy's Laboratories (NSE:DRREDDY) Will Pay A Dividend Of ₹40.00

Jun 23
Dr. Reddy's Laboratories (NSE:DRREDDY) Will Pay A Dividend Of ₹40.00

Additional Considerations Required While Assessing Dr. Reddy's Laboratories' (NSE:DRREDDY) Strong Earnings

Jun 20
Additional Considerations Required While Assessing Dr. Reddy's Laboratories' (NSE:DRREDDY) Strong Earnings

Dr. Reddy's Laboratories (NSE:DRREDDY) Is Paying Out A Dividend Of ₹40.00

May 26
Dr. Reddy's Laboratories (NSE:DRREDDY) Is Paying Out A Dividend Of ₹40.00

Dr. Reddy's Laboratories (NSE:DRREDDY) Will Pay A Dividend Of ₹40.00

May 10
Dr. Reddy's Laboratories (NSE:DRREDDY) Will Pay A Dividend Of ₹40.00

With EPS Growth And More, Dr. Reddy's Laboratories (NSE:DRREDDY) Makes An Interesting Case

May 06
With EPS Growth And More, Dr. Reddy's Laboratories (NSE:DRREDDY) Makes An Interesting Case

There Is A Reason Dr. Reddy's Laboratories Limited's (NSE:DRREDDY) Price Is Undemanding

Apr 18
There Is A Reason Dr. Reddy's Laboratories Limited's (NSE:DRREDDY) Price Is Undemanding

Earnings Beat: Dr. Reddy's Laboratories Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Feb 02
Earnings Beat: Dr. Reddy's Laboratories Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Should You Be Adding Dr. Reddy's Laboratories (NSE:DRREDDY) To Your Watchlist Today?

Jan 19
Should You Be Adding Dr. Reddy's Laboratories (NSE:DRREDDY) To Your Watchlist Today?

Why Investors Shouldn't Be Surprised By Dr. Reddy's Laboratories Limited's (NSE:DRREDDY) Low P/E

Jan 01
Why Investors Shouldn't Be Surprised By Dr. Reddy's Laboratories Limited's (NSE:DRREDDY) Low P/E

Dr. Reddy's Laboratories (NSE:DRREDDY) Has A Rock Solid Balance Sheet

Oct 21
Dr. Reddy's Laboratories (NSE:DRREDDY) Has A Rock Solid Balance Sheet

If EPS Growth Is Important To You, Dr. Reddy's Laboratories (NSE:DRREDDY) Presents An Opportunity

Oct 03
If EPS Growth Is Important To You, Dr. Reddy's Laboratories (NSE:DRREDDY) Presents An Opportunity

Dr. Reddy's Laboratories (NSE:DRREDDY) Could Easily Take On More Debt

Jul 14
Dr. Reddy's Laboratories (NSE:DRREDDY) Could Easily Take On More Debt

Dr. Reddy's Laboratories (NSE:DRREDDY) Is Increasing Its Dividend To ₹40.00

Jun 24
Dr. Reddy's Laboratories (NSE:DRREDDY) Is Increasing Its Dividend To ₹40.00

Dr. Reddy's Laboratories (NSE:DRREDDY) Is Paying Out A Larger Dividend Than Last Year

Jun 10
Dr. Reddy's Laboratories (NSE:DRREDDY) Is Paying Out A Larger Dividend Than Last Year

Dr. Reddy's Laboratories (NSE:DRREDDY) Is Increasing Its Dividend To ₹40.00

May 27
Dr. Reddy's Laboratories (NSE:DRREDDY) Is Increasing Its Dividend To ₹40.00

Dr. Reddy's Laboratories' (NSE:DRREDDY) Dividend Will Be Increased To ₹40.00

May 13
Dr. Reddy's Laboratories' (NSE:DRREDDY) Dividend Will Be Increased To ₹40.00

Is Dr. Reddy's Laboratories (NSE:DRREDDY) Using Too Much Debt?

Apr 11
Is Dr. Reddy's Laboratories (NSE:DRREDDY) Using Too Much Debt?

If EPS Growth Is Important To You, Dr. Reddy's Laboratories (NSE:DRREDDY) Presents An Opportunity

Mar 06
If EPS Growth Is Important To You, Dr. Reddy's Laboratories (NSE:DRREDDY) Presents An Opportunity

These 4 Measures Indicate That Dr. Reddy's Laboratories (NSE:DRREDDY) Is Using Debt Reasonably Well

Jan 10
These 4 Measures Indicate That Dr. Reddy's Laboratories (NSE:DRREDDY) Is Using Debt Reasonably Well

If EPS Growth Is Important To You, Dr. Reddy's Laboratories (NSE:DRREDDY) Presents An Opportunity

Dec 05
If EPS Growth Is Important To You, Dr. Reddy's Laboratories (NSE:DRREDDY) Presents An Opportunity

CEO報酬分析

Dr. Reddy's Laboratories の収益と比較して、Erez Israeli の報酬はどのように変化したか?
日付総報酬給与会社業績
Sep 30 2024n/an/a

₹53b

Jun 30 2024n/an/a

₹56b

Mar 31 2024₹197mn/a

₹56b

Dec 31 2023n/an/a

₹52b

Sep 30 2023n/an/a

₹51b

Jun 30 2023n/an/a

₹47b

Mar 31 2023₹195mn/a

₹45b

Dec 31 2022n/an/a

₹36b

Sep 30 2022n/an/a

₹31b

Jun 30 2022n/an/a

₹30b

Mar 31 2022₹127mn/a

₹24b

Dec 31 2021n/an/a

₹26b

Sep 30 2021n/an/a

₹19b

Jun 30 2021n/an/a

₹17b

Mar 31 2021₹120mn/a

₹17b

Dec 31 2020n/an/a

₹21b

Sep 30 2020n/an/a

₹15b

Jun 30 2020n/an/a

₹19b

Mar 31 2020₹195m₹107m

₹19b

Dec 31 2019n/an/a

₹16b

Sep 30 2019n/an/a

₹27b

Jun 30 2019n/an/a

₹21b

Mar 31 2019₹123mn/a

₹19b

報酬と市場: Erezの 総報酬 ($USD 2.33M ) は、 Indian市場 ($USD 1.08M ) の同規模の企業の平均を上回っています。

報酬と収益: Erezの報酬は、過去 1 年間の会社の業績と一致しています。


CEO(最高経営責任者

Erez Israeli (56 yo)

6.6yrs

在職期間

₹197,090,000

報酬

Mr. Erez Israeli, MBA has been Chief Executive Officer of Dr. Reddy's Laboratories Limited since August 1, 2019 and has been its Member of the Management Council since April 02, 2018. Mr. Israeli served as...


リーダーシップ・チーム

名称ポジション在職期間報酬所有権
Gunupati Prasad
Co-Chairman38.6yrs₹186.28m13.07%
₹ 130.7b
Kallam Reddy
Chairman of the Board & Member of the Management Council31.8yrs₹116.17m13.61%
₹ 136.1b
Erez Israeli
CEO & Member of the Management Council6.6yrs₹197.09m0.0066%
₹ 65.5m
Mannam Venkatanarasimham
CFO & Member of the Management Councilless than a year₹48.82m0.0057%
₹ 56.7m
Krishna Venkatesh
Global Head of Quality and Pharmacovigilance & Member of the Management Councilless than a year₹6.15mデータなし
Deepak Sapra
CEO of API & Services & Member of Management Councilno data₹41.90m0.0027%
₹ 26.8m
Venkata Motupalli
CEO of Branded Markets - India & Emerging Countries and Member of Management Councilno data₹82.74m0.016%
₹ 157.3m
Archana Bhaskar
EVP, Head of Corporate Communications7.4yrs₹65.21m0.0063%
₹ 63.5m
Sanjay Sharma
Executive VP7.3yrs₹66.05mデータなし
Patrick Aghanian
CEO of European Generics & Member of Management Councilno data₹63.09mデータなし
Sushrut Kulkarni
Global Head of Integrated Product Development Organisation & Member of the Management Councilno data₹55.63m0.000020%
₹ 200.0k
Jayanth Sridhar
Global Head – Biologics & Member of the Management Councilno data₹34.59mデータなし

6.6yrs

平均在職期間

56yo

平均年齢

経験豊富な経営陣: DRREDDYの経営陣は経験豊富で経験豊富です(平均在職期間は6.6年)。


取締役

名称ポジション在職期間報酬所有権
Gunupati Prasad
Co-Chairman38.6yrs₹186.28m13.07%
₹ 130.7b
Kallam Reddy
Chairman of the Board & Member of the Management Council31.8yrs₹116.17m13.61%
₹ 136.1b
R. Rajgopalan
Member of the Scientific Advisory Boardno data₹8.36mデータなし
Arun Kumar
Independent Director2.3yrs₹18.77mデータなし
Shikha Sharma
Independent Director5.8yrs₹13.34mデータなし
K. Reddy
Member of the Scientific Advisory Boardno dataデータなしデータなし
Leo Puri
Lead Independent Director6.1yrs₹17.10mデータなし
Kodumudi Krishnan
Independent Director2.8yrs₹14.18mデータなし
Sanjiv Mehta
Independent Directorless than a year₹3.32mデータなし
Alpna Seth
Independent Director1.8yrs₹8.25mデータなし
Penny Wan
Independent Director2.8yrs₹17.10mデータなし
Claudio Albrecht
Independent Director1.5yrs₹16.09mデータなし

2.8yrs

平均在職期間

64yo

平均年齢

経験豊富なボード: DRREDDYの 取締役会経験豊富 ではない ( 2.8年の平均在任期間) ため、新しい取締役会が必要であると考えられます。